What does trilink — acquisitions mean?

Tracks the capital deployed for the purchase of businesses or technologies specifically integrated into the TriLink segment. This metric highlights the company's inorganic growth strategy and its commitment to expanding its nucleic acid production capabilities. It is a critical indicator of how the company allocates capital to maintain a competitive edge in drug therapy and vaccine development support.

Maravai LifeSciences Holdings, Inc. MRVI TriLink — Acquisitions

Other segment segments

Cygnus

$0—

Similar metrics at other companies

ABMTechnical Solutions — Acquisitions

$3.68M-81.8%

QCOMQtl — Acquisitions

$0—

STCCorporate — Acquisitions

$0—

STCTitle — Acquisitions

$2.19M-74.6%

GDTechnologies — Acquisitions

-$4M-131%

ARRYSTI Operations — Acquisition

$0—

Other financials

Income statement

See full

Revenue$65.8M+40.5%

Gross profit$33.7M+336%

Operating income-$2.2M+95.6%

Net income-$3.7M+87.5%

EPS (diluted)-$0.02+90.5%

Balance sheet

See full

Cash & equivalents$165.9M-41.8%

Total debt$270.9M-17.1%

Total equity$211.6M-29.6%

Total assets$713.2M-25.7%

Cash flow

See full

Operating cash flow$8.7M+192%

CapEx$4.4M-1.4%

Free cash flow$4.2M+130%

Valuation

See full

Market cap$902.74M+204%

Enterprise value$1.01B+198%

P/S4.4×+3.2×

Profitability

See full

Gross margin29.3%-8.0pp

Operating margin-82.2%-16.6pp

Net margin-51.1%-9.9pp

FCF margin-25.7%—

Returns & leverage

See full

Return on equity-40.8%-4.0pp

Debt / equity1.3×+0.2×

Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — acquisitions.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s trilink — acquisitions?: Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — acquisitions of $3.05M in Q4 2025.
What does trilink — acquisitions mean?: Tracks the capital deployed for the purchase of businesses or technologies specifically integrated into the TriLink segment. This metric highlights the company's inorganic growth strategy and its commitment to expanding its nucleic acid production capabilities. It is a critical indicator of how the company allocates capital to maintain a competitive edge in drug therapy and vaccine development support.